European Urology

Viewing slides 1-6 of 8

• S0302-2838(12)00909-8.title drag remove slide sort drag into slide Title Advanced Prostate Cancer Treated with Intermittent or Continuous Androgen Deprivation in the Randomised FinnProstate Study VII: Quality of Life and Adverse Effects
  
  Arto J. Salonen, Kimmo Taari, ... Advanced Prostate Cancer Treated with Intermittent or Continuous Androgen Deprivation in the ... Zoom
• S0302-2838(12)00909-8.introduction drag remove slide sort drag into slide Introduction • The standard treatment for advanced prostate cancer (PCa) has been androgen-deprivation therapy (ADT).
  
  • Well-known side effects of ADT are hot flushes, night sweats, erectile ... • The standard treatment for advanced prostate cancer (PCa) has been androgen-deprivation ... Zoom
• 22720 drag remove slide sort drag into slide Differences in quality of life between treatment arms according to ... Zoom read this article »
• 22722 drag remove slide sort drag into slide Differences in quality of life between treatment arms in the domains of ... Zoom read this article »
• 22724 drag remove slide sort drag into slide Proportion of respondents in domain 9 (sexual functioning) who continued to ... Zoom read this article »
• S0302-2838(12)00909-8.materials_and_methods drag remove slide sort drag into slide Materials and methods • A total of 852 men with advanced PCa were enrolled to receive goserelin acetate 3.6 mg every 28 d for 24 wk.
  
  • A total of 554 patients whose prostate-specific antigen (PSA) decreased ... • A total of 852 men with advanced PCa were enrolled to receive goserelin acetate 3.6 mg every ... Zoom

Viewing slides 1-6 of 8